- Home
- SBH vs FTRE Comparison
SBH vs FTRE Comparison
Compare SBH & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | FTRE |
|---|---|---|
| Founded | 1964 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBH | FTRE |
|---|---|---|
| Price | $15.93 | $15.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $14.83 | ★ $15.56 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 02-12-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $3,701,424,000.00 | $2,759,900,000.00 |
| Revenue This Year | $2.04 | $3.17 |
| Revenue Next Year | $1.62 | $0.07 |
| P/E Ratio | $8.32 | ★ N/A |
| Revenue Growth | N/A | ★ 1.88 |
| 52 Week Low | $7.54 | $3.97 |
| 52 Week High | $17.40 | $19.00 |
Technical Indicators
Market Signals| Indicator | SBH | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 46.80 |
| Support Level | $15.42 | $16.98 |
| Resistance Level | $16.00 | $18.62 |
| Average True Range (ATR) | 0.62 | 1.00 |
| MACD | 0.13 | -0.31 |
| Stochastic Oscillator | 95.69 | 4.37 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.